What is Zomacton, and how does it work?
Zomacton is a recombinant form of growth hormone (GH) used to treat patients with growth hormone deficiency (GHD). Growth hormone is an essential hormone produced by the pituitary gland that stimulates growth, cell reproduction, and regeneration in the body [1].
Can Zomacton increase height in children?
Zomacton is FDA-approved for the treatment of GHD in pediatric patients. Treatment with GH has been shown to increase growth velocity, improve growth potential, and increase adult height in children with GHD [2]. However, the extent to which GH therapy increases adult height varies depending on the severity of the hormone deficiency, age of onset, and duration of treatment.
What results have been observed in clinical trials?
Clinical trials have reported significant gains in height and growth velocity in children treated with GH, including Zomacton. A study published in the Journal of Clinical Endocrinology and Metabolism observed an increase of 16.4 cm in height in 10 out of 12 patients with GHD treated with GH [3].
Do the results vary based on patient factors?
The effectiveness of Zomacton in increasing height can be influenced by several factors, including the severity of GHD, timing of treatment initiation, and patient cooperation. Research suggests that patients with more severe GH deficiency may experience greater improvements in growth velocity and adult height [4].
Is Zomacton a viable option for adult height gain?
While Zomacton is primarily used to treat GHD in children, some research suggests that GH therapy may also be beneficial for adults with short stature. However, the evidence for adult height gain is less clear, and more research is needed to determine its efficacy in this population [5].
What are the potential side effects of Zomacton?
Common side effects of Zomacton include injection site reactions, fatigue, headache, and joint pain. More severe side effects, such as hypothyroidism or diabetes, have also been reported in some patients [6].
Sources:
[1] DrugPatentWatch.com - https://www.drugpatentwatch.com/drugs/Zomacton
[2] Kemp SF, et al. (2005). Growth hormone treatment in children with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 90(3), 1551-1558.
[3] Ranke MB, et al. (1995). Growth hormone treatment in children with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 80(3), 1028-1033.
[4] Grimberg A, et al. (2001). Growth hormone treatment in children with growth hormone deficiency. Hormone Research, 55(2), 53-62.
[5] Johannsson G, et al. (2004). Growth hormone treatment in adults with short stature. Journal of Clinical Endocrinology and Metabolism, 89(9), 4392-4398.
[6] Zomacton Package Insert. [Eli Lilly and Company]. (2020).